Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00878319Not ApplicableCompleted

Operative and Nonoperative Treatment of Humeral Shaft Fractures

Role: collaborator

NCT05231343Not ApplicableRecruiting

Comparing Dual Mini-fragment Plating to Single Precontoured Plating of Acute Midshaft Clavicle Fractures Trial

Role: collaborator

NCT00856479Phase 4Withdrawn

A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures

Role: collaborator

NCT01123447Not ApplicableUnknown

Surgical Treatment Versus Non-surgical Treatment of Ulnar Fractures

Role: collaborator

NCT03868280Not ApplicableUnknown

The FLiP Study, a Pilot Cluster Randomized Trial

Role: collaborator

All 5 trials loaded